Citation

Skerlj R, Bridger G, Zhou Y, Bourque E, McEachern E, Metz M, Harwig C, Li TS, Yang W, Bogucki D, Zhu Y, Langille J, Veale D, Ba T, Bey M, Baird I, Kaller A, Krumpak M, Leitch D, Satori M, Vocadlo K, Guay D, Nan S, Yee H, Crawford J, Chen G, Wilson T, Carpenter B, Gauthier D, Macfarland R, Mosi R, Bodart V, Wong R, Fricker S, Schols D.: Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication. J Med Chem, Volume 56 (20), 2013

Authors

Ba T, Baird I, Bey M, Bodart V, Bogucki D, Bourque E, Bridger G, Carpenter B, Chen G, Crawford J, Fricker S, Gauthier D, Guay D, Harwig C, Kaller A, Krumpak M, Langille J, Leitch D, Li TS, Macfarland R, McEachern E, Metz M, Mosi R, Nan S, Satori M, Schols D., Skerlj R, Veale D, Vocadlo K, Wilson T, Wong R, Yang W, Yee H, Zhou Y, Zhu Y

Journal

J Med Chem

Year

2013

DOI

10.1021/jm401101p

PubMed

24090135

Machine-readable

REST APIRDF